Chromocell Therapeutics Corp (CHRO)
1.75
-0.26
(-12.94%)
USD |
NYAM |
May 17, 16:00
1.75
0.00 (0.00%)
After-Hours: 20:00
Chromocell Therapeutics Cash from Investing (TTM)
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
iBio Inc | 8.285M |
Lixte Biotechnology Holdings Inc | -- |
PDS Biotechnology Corp | -- |
Syros Pharmaceuticals Inc | 38.44M |
Nutriband Inc | -0.0518M |